Impact of microarray data quality on genomic data submissions to the FDA

被引：35

作者：

Frueh, Felix W. ^{[1
]}

机构：

[1] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA

来源：

关键词：

D O I：

10.1038/nbt0906-1105

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

How can microarray data best be exploited and integrated into the regulatory decision-making process?

引用

页码：1105 / 1107

页数：3

共 4 条

[1] Initial sequencing and analysis of the human genome
Lander, ES
Int Human Genome Sequencing Consortium
Linton, LM
Birren, B
Nusbaum, C
Zody, MC
Baldwin, J
Devon, K
Dewar, K
Doyle, M
FitzHugh, W
Funke, R
Gage, D
Harris, K
Heaford, A
Howland, J
Kann, L
Lehoczky, J
LeVine, R
McEwan, P
McKernan, K
Meldrim, J
Mesirov, JP
Miranda, C
Morris, W
Naylor, J
Raymond, C
Rosetti, M
Santos, R
Sheridan, A
Sougnez, C
Stange-Thomann, N
Stojanovic, N
Subramanian, A
Wyman, D
Rogers, J
Sulston, J
Ainscough, R
Beck, S
Bentley, D
Burton, J
Clee, C
Carter, N
Coulson, A
Deadman, R
Deloukas, P
Dunham, A
Dunham, I
Durbin, R
French, L
[J]. NATURE, 2001, 409 (6822) : 860 - 921
[2] Pharmacogenomic-guided drug development: Regulatory perspective
Lesko L.J.
Woodcock J.
[J]. The Pharmacogenomics Journal, 2002, 2 (1) : 20 - 24
[3] Cross-platform comparability of microarray technology: Intra-platform consistency and appropriate data analysis procedures are essential
Shi, LM
Tong, WD
Fang, H
Scherf, U
Han, J
Puri, RK
Frueh, FW
Goodsaid, FM
Guo, L
Su, ZQ
Han, T
Fuscoe, JC
Xu, ZA
Patterson, TA
Hong, HX
Xie, Q
Perkins, RG
Chen, JJ
Casciano, DA
[J]. BMC BIOINFORMATICS, 2005, 6 (Suppl 2)
[4] QA/QC: challenges and pitfalls facing the microarray community and regulatory agencies
Shi, LM
Tong, WD
Goodsaid, F
Frueh, FW
Fang, H
Han, T
Fuscoe, JC
Casciano, DA
[J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2004, 4 (06) : 761 - 777